🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Some recent experiments in getting external scrutiny on GiveWell grants — forecasting the mortality effects of chlorine, qualitative research on vitamin A in Nigeria, and hearing from LMIC policymakers ⤵️

This is an incredibly subtle, yet provocative paper. If you think we should treat future humans the same as present humans, then it implies that we should have massive transfers from old to young, even if wasteful! Let me show you why 1/

Nature publishes peer review comments alongside new papers - Research Professional News buff.ly/W7NEWfC

Very interesting new paper on the production of development economics via opening new JPAL and IPA offices from Wilson King : - RCTs about a country robustly increase (and ~continue to grow) - How big is an effect of 2-5 RCTs in 10 years? - Spillovers across borders are + not -

How biased are reading tests against Blacks and Hispanics? To what extent are disparities the result of unfair test questions? Bias does exist, but it explains very little — only 4 percent of the gap. 1/

This account is a very good example of “you can just do things”

There will be a time when we look back on most attempts to elevate “indigenous ways of knowing” and see them as a pretty pure manifestation of the noble savage trope.

Interesting ideas in here on alternative ways to share and review scientific work beyond publishing in journals

🤔 asteriskmag.com/issues/10/can-…

Kinds of science True & Replicable: photoelectric effect False & non-Replicable: many priming results F & Replicable: bad analyses like confounded country-level regressions T & non-Replicable: badly documented experiments, unique observations I think there's a lot of F&R

One of the final lectures for the research methods course I’m taking was an introduction to using Copilot in R. Finally working with it on one of my coding projects and I understand why we were advised not to use it until after we had completed our problem sets

Prevention beats cure, which is why it's so exciting that Lenacapavir, a twice-yearly HIV preventative, just got approved for the first time (by the FDA) Why is it such a big deal? When trialled (in women in South Africa and Uganda) there were 0 HIV infections 🧵

One puzzle for me, having done tours in academia, government, and industry, is why research positions in academia/government require letters of reference. Research output is publicly observable, and interviews can further uncover any additional information about a candidate.

My first reaction seeing his newsers…. “You mean…. you can just answer a question… wiithout giving an extended unrelated monologue stuffed with talking points…. Is this even legal in Canada?”